Alfonso G Zulueta's Net Worth
$63.1 Million
Who is Alfonso G Zulueta?
Alfonso G Zulueta has an estimated net worth of $63.1 Million. This is based on reported shares across multiple companies, which include Syneos Health, Inc., LILLY ELI & CO, CTS CORP, AMARIN CORP PLC\UK, and Calidi Biotherapeutics, Inc..
SEC CIK
Alfonso G Zulueta's CIK is 0001596336
Past Insider Trading and Trends
2020 was Alfonso G Zulueta's most active year for acquiring shares with 9 total transactions. Alfonso G Zulueta's most active month to acquire stocks was the month of January. 2019 was Alfonso G Zulueta's most active year for disposing of shares, totalling 10 transactions. Alfonso G Zulueta's most active month to dispose stocks was the month of January. 2021 saw Alfonso G Zulueta paying a total of $6,107,027.49 for 60,097 shares, this is the most they've acquired in one year. In 2019 Alfonso G Zulueta cashed out on 76,086 shares for a total of $7,720,528.52, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Syneos Health, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -8.36K |
$43.00 | -$150,199.00 |
0
|
Sep 28
| |||
Form 4
| +139.22% | 4.86K |
—
|
—
| 8.36K |
May 25
| |||
Form 4
| +434.10% | 2.84K |
—
|
—
| 3.49K |
May 25
| |||
Form 4
|
∞
| 654 |
—
|
—
| 654 |
Jan 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ELI LILLY & Co (LLY) Snapshot price: $900.9999
SVP & President, Lilly Int'l
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +104.04% | 29.04K |
$205.77 | $5,974,943.49 | 56.95K |
Feb 8
| |||
Form 4
| +49.68% | 9.26K |
$207.97 | -$1,557,695.30 | 27.91K |
Feb 1
| |||
Form 4
| -37.10% | -11.00K |
$170.00 | -$1,870,000.00 | 18.65K |
Scheduled
|
Jul 9
| ||
Form 4
| -36.44% | -17.00K |
$162.94 | -$2,770,000.00 | 29.65K |
Scheduled
|
Jun 16
| ||
Form 4
| -17.65% | -10.00K |
$150.00 | -$1,500,000.00 | 46.65K |
Scheduled
|
Jun 5
| ||
Form 4
| +47.81% | 18.32K |
—
|
—
| 56.65K |
Feb 11
| |||
Form 4
| +30.77% | 9.02K |
$139.64 | -$1,019,232.36 | 38.32K |
Feb 1
| |||
Form 4
| -13.31% | -4.50K |
$120.00 | -$540,000.00 | 29.31K |
Scheduled
|
Dec 6
| ||
Form 4
| -11.75% | -4.50K |
$117.00 | -$526,500.00 | 33.81K |
Scheduled
|
Sep 20
| ||
Form 4/A
| -33.73% | -19.50K |
$112.96 | -$2,202,714.48 | 38.31K |
Scheduled
|
Sep 3
| ||
Form 4
| -33.73% | -19.50K |
$112.91 | -$2,201,745.00 | 38.31K |
Scheduled
|
Sep 3
| ||
Form 4
| -14.75% | -10.00K |
$124.65 | -$1,246,500.00 | 57.81K |
Scheduled
|
Apr 12
| ||
Form 4
| +45.56% | 21.22K |
$120.17 | $2,550,488.08 | 67.81K |
Feb 4
| |||
Form 4
| +13.00% | 5.36K |
$119.86 | -$523,069.04 | 46.58K |
Feb 1
| |||
Form 4
| -8.84% | -4.00K |
$120.00 | -$480,000.00 | 41.22K |
Scheduled
|
Jan 31
| ||
Form 4
| -13.40% | -7.00K |
$114.64 | -$802,480.00 | 45.22K |
Scheduled
|
Oct 4
| ||
Form 4
| -10.31% | -6.00K |
$106.31 | -$637,830.00 | 52.22K |
Scheduled
|
Sep 17 - Sep 18
| ||
Form 4
| +17.95% | 8.86K |
$81.45 | -$580,982.85 | 58.22K |
Feb 1
| |||
Form 4
| +23.26% | 9.32K |
$87.60 | $816,081.60 | 49.36K |
Jan 29
| |||
Form 4
| -8.10% | -3.53K |
$86.00 | -$303,752.00 | 40.05K |
Scheduled
|
Dec 4
| ||
Form 4
| -4.39% | -2.00K |
$83.67 | -$167,591.01 | 43.58K |
Scheduled
|
Nov 10
| ||
Form 4
| -24.76% | -15.00K |
$77.66 | -$1,164,900.00 | 45.58K |
Feb 6
| |||
Form 4
| +6.19% | 3.53K |
$77.03 | -$240,872.81 | 60.58K |
Feb 1
| |||
Form 4
| +29.95% | 13.15K |
$75.38 | $991,247.00 | 57.05K |
Jan 27
| |||
Form 4
| -21.02% | -12.00K |
$76.27 | -$915,240.00 | 45.1K |
Apr 27
| |||
Form 4
| -8.05% | -5.00K |
$78.75 | -$393,750.00 | 57.1K |
Jan 29
| |||
Form 4
| +12.78% | 7.04K |
$81.96 | $576,588.60 | 62.1K |
Jan 26
| |||
Form 4
| +4.51% | 2.37K |
$69.95 | -$133,050.64 | 55.07K |
Nov 20
| |||
Form 4
| +28.02% | 11.53K |
$70.97 | $818,426.04 | 52.69K |
Jan 28
| |||
Form 4
| +5.24% | 2.05K |
$61.30 | -$103,791.54 | 41.16K |
Nov 7
| |||
Form 4
| +14.49% | 4.95K |
$64.85 | -$284,302.40 | 39.11K |
Oct 1
| |||
Form 4
| +49.64% | 11.33K |
$54.23 | $614,588.59 | 34.16K |
Jan 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CTS CORP (CTS) Snapshot price: $45.28
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +13.63% | 3.6K |
—
|
—
| 30.01K |
Nov 2
| |||
Form 4
| +13.30% | 3.1K |
—
|
—
| 26.41K |
Nov 10
| |||
Form 4
| +18.26% | 3.6K |
$36.69 | $132,084.00 | 23.31K |
Nov 4
| |||
Form 4
| +27.07% | 4.2K |
$29.23 | $122,766.00 | 19.71K |
Nov 5
| |||
Form 4
| +25.73% | 2.66K |
$22.40 | $59,638.97 | 13.01K |
Mar 11 - Mar 13
| |||
Form 4
| +20.35% | 1.75K |
$22.83 | $39,954.50 | 10.35K |
Mar 9 - Mar 10
| |||
Form 4
| +104.76% | 4.4K |
$27.81 | $122,364.00 | 8.6K |
Nov 7
| |||
Form 4
|
∞
| 4.2K |
$28.85 | $121,170.00 | 4.2K |
Nov 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AMARIN CORP PLC\UK (AMRN) Snapshot price: $0.6094
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Calidi Biotherapeutics, Inc. (CLDI) Snapshot price: $1.17
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +4.42% | 5.64K |
$1.80 | $10,159.20 | 133.3K |
Dec 21
| |||
| No matching records found | |||||||||